1.7100 -0.06 (-3.39%)
Before hours: 8:18AM EDT
|Bid||1.7000 x 2900|
|Ask||1.7000 x 1200|
|Day's Range||1.7100 - 1.8800|
|52 Week Range||0.2800 - 4.3900|
|Beta (5Y Monthly)||1.45|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Looking into the current session, SINTX Technologies Inc. (NASDAQ: SINT) shares are trading at $2.62, after a 239.60% increase. Moreover, over the past month, the stock increased by 294.40%, but in the past year, fell by 8.93%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session.The stock is currently above from its 52 week low by 3519.86%. Assuming that all other factors are held constant, this could present itself as an opportunity for investors trying to diversify their portfolio with Medical Devices stocks, and capitalize on the lower share price observed over the year.The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.Most often, an industry will prevail in a particular phase of a business cycle, than other industries.Compared to the aggregate P/E ratio of the 0.02 in the Medical Devices industry, SINTX Technologies Inc. has a lower P/E ratio of 0.0. Shareholders might be inclined to think that they might perform worse than its industry peers. It's also possible that the stock is undervalued.P/E ratio is not always a great indicator of the company's performance. Depending on the earnings makeup of a company, investors may not be able to attain key insights from trailing earnings.See more from Benzinga * 17 Healthcare Stocks Moving In Monday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of SiNtx Technologies Inc. skyrocketed more than 4-fold (up 343%) in premarket trading Monday, after the original equipment manufacturer ceramics company said the SARS-CoV-2 virus which causes COVID-19 was "inactivated" when exposed to its sintered silicon nitride powder in a controlled laboratory study. Trading volume spiked to over 847,000 shares ahead of the open, already more than half full-day average of about 1.4 million shares. The company said it will share additional data soon, once the findings are published. SiNtx said it was conducting additional testing at independent laboratories to corroborate the results. "The antiviral data are consistent with the well-established anti-bacterial properties of SINTX's silicon nitride, and with previously reported effectiveness against several single-strand RNA viruses," said Chief Executive Sonny Bal. The stock's rally comes as futures for the S&P 500 rose 0.9% ahead of the open.
If you're interested in Sintx Technologies, Inc. (NASDAQ:SINT), then you might want to consider its beta (a measure of...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Sintx Technologies (NASDAQ: SINT ) shares ...
The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT ) boasts five near-term catalysts that should help the stock double in value, according ...
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. ACADIA Pharmaceuticals (NASDAQ: ACAD ) shares ...
Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. NVIDIA (NASDAQ: NVDA ) shares were up 5.7% ...